Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nintedanib in Advanced or Recurrent Endometrial Cancer
NCT02730416Phase 2Completed
- Sponsor
- Nordic Society of Gynaecological Oncology Clinical Trial Unit
- Start
- Dec 2016
- Primary completion
- Oct 2021
- Countries
- 7
01
Overview
A Phase 2 trial of nintedanib intravenous solution in endometrial cancer (EC), sponsored by Nordic Society of Gynaecological Oncology Clinical Trial Unit. Started Dec 2016; status: completed.
02
Drugs
nintedanib intravenous solution
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT02730416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02730416.